Abstract
Advances in genetic, pharmacologic, and sequencing technology have led to new insight into the role of lymphatics in health and disease. This includes fundamental aspects of the crosstalk between immune cells with cardiac lymphatics. At the interface between leukocytes and lymphatic endothelial cells, myeloid populations are sources of lymphatic growth factors during inflammation. Lymphatic endothelial cells also secrete signals that activate leukocytes, including to antigen presenting cells. Taken together, a view of the lymphatic vasculature as a supplemental cardiac immune hub is emerging. Herein, we discuss reciprocal cell and molecular crosstalk between leukocytes and lymphatics in the myocardium, with implications for health and cardiac inflammation.
Original language | English (US) |
---|---|
Pages (from-to) | 13-20 |
Number of pages | 8 |
Journal | Journal of Molecular and Cellular Cardiology |
Volume | 198 |
DOIs | |
State | Published - Jan 2025 |
Funding
Supported by NIH R01HL122309 and by the Sidney and Bess Eisenberg Memorial Endowment.
Keywords
- Lymphatic endothelial cell
- Macrophage
- Myocardial infarction
ASJC Scopus subject areas
- Molecular Biology
- Cardiology and Cardiovascular Medicine